Allscripts Healthcare Solutions, Inc provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), connectivity, private cloud hosting, outsourcing, analytics, patient engagement, clinical decision support, and population health management solutions.
Read More…
Industry, Sector and Symbol
Industry Computer integrated systems design
Sub-IndustryHealth Care Technology
SectorMedical
Phone800-334-8534
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$1.75 billion
Profitability
Miscellaneous
Employees9,500
Next Earnings Date11/7/2019 (Estimated)
OptionableOptionable
Allscripts Healthcare Solutions (NASDAQ:MDRX) Frequently Asked Questions
What is Allscripts Healthcare Solutions' stock symbol?
Allscripts Healthcare Solutions trades on the NASDAQ under the ticker symbol "MDRX."
How will Allscripts Healthcare Solutions' stock buyback program work?
Allscripts Healthcare Solutions declared that its board has approved a share buyback program on Thursday, August 2nd 2018, which authorizes the company to repurchase $250,000,000.00 in outstanding shares, according to EventVestor. This repurchase authorization authorizes the company to purchase up to 11.3% of its stock through open market purchases. Stock repurchase programs are usually an indication that the company's management believes its stock is undervalued.
How were Allscripts Healthcare Solutions' earnings last quarter?
Allscripts Healthcare Solutions Inc (NASDAQ:MDRX) issued its quarterly earnings data on Thursday, August, 8th. The software maker reported $0.17 earnings per share for the quarter, beating the Thomson Reuters' consensus estimate of $0.16 by $0.01. The software maker had revenue of $444.50 million for the quarter, compared to analysts' expectations of $449.03 million. Allscripts Healthcare Solutions had a return on equity of 6.17% and a net margin of 9.85%. Allscripts Healthcare Solutions's revenue was up .7% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $0.18 earnings per share. View Allscripts Healthcare Solutions' Earnings History.
When is Allscripts Healthcare Solutions' next earnings date?
What guidance has Allscripts Healthcare Solutions issued on next quarter's earnings?
Allscripts Healthcare Solutions issued an update on its FY19 earnings guidance on Thursday, August, 8th. The company provided earnings per share (EPS) guidance of $0.65-0.70 for the period, compared to the Thomson Reuters consensus estimate of $0.68.
What price target have analysts set for MDRX?
10 brokers have issued 12-month target prices for Allscripts Healthcare Solutions' stock. Their forecasts range from $10.00 to $15.00. On average, they anticipate Allscripts Healthcare Solutions' stock price to reach $12.19 in the next twelve months. This suggests a possible upside of 15.9% from the stock's current price. View Analyst Price Targets for Allscripts Healthcare Solutions.
What is the consensus analysts' recommendation for Allscripts Healthcare Solutions?
10 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Allscripts Healthcare Solutions in the last year. There are currently 7 hold ratings and 3 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Allscripts Healthcare Solutions.
What are Wall Street analysts saying about Allscripts Healthcare Solutions stock?
Here are some recent quotes from research analysts about Allscripts Healthcare Solutions stock:
- 1. Cantor Fitzgerald analysts commented, ". We reiterate our Neutral rating on MDRX shares and maintain our price target at $10, After the market close on Thursday, May 2, MDRX reported 1Q19 results, with revenue slightly below our estimate. 1Q19 bookings increased 9% y/y. MDRX reiterated its 2019 guidance for non-GAAP EPS and bookings. The company continues its policy of not providing full year revenue guidance, but provided 2Q19 revenue guidance, which was below our estimate but in line with FactSet consensus. We note the company had previously provided a modest three-year CAGR outlook." (5/2/2019)
- 2. According to Zacks Investment Research, "Allscripts continues to gain from its Software, Delivery, Support and Maintenance units, which delivered solid growth in the last couple of quarters. Significant growth in bookings also buoys optimism. The company’s growth in revenue cycle services along with the recently-closed acquisition of HealthGrid is likely to boost its FollowMyHealth patient engagement platform. Apart from these, management is optimistic about the collaboration with Microsoft made in the recent past. On the flip side, the company’s core Client Services unit has reported dismal performance in recent times. Also, Allscripts saw significant margin contraction in the last reported quarter. The company is exposed to integration risks. Intense competition in the niche space is an added concern. Over the past year, Allscripts has underperformed its industry." (4/24/2019)
Has Allscripts Healthcare Solutions been receiving favorable news coverage?
News headlines about MDRX stock have been trending very negative this week, according to InfoTrie. The research group identifies negative and positive press coverage by analyzing more than six thousand blog and news sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Allscripts Healthcare Solutions earned a coverage optimism score of -3.3 on InfoTrie's scale. They also gave media coverage about the software maker a news buzz of 10.0 out of 10, indicating that recent press coverage is extremely likely to have an impact on the company's share price in the immediate future. View News Stories for Allscripts Healthcare Solutions.
Are investors shorting Allscripts Healthcare Solutions?
Allscripts Healthcare Solutions saw a decrease in short interest in the month of September. As of September 15th, there was short interest totalling 21,690,000 shares, a decrease of 5.5% from the August 15th total of 22,960,000 shares. Based on an average daily volume of 1,770,000 shares, the short-interest ratio is currently 12.3 days. Currently, 13.3% of the company's stock are short sold. View Allscripts Healthcare Solutions' Current Options Chain.
Who are some of Allscripts Healthcare Solutions' key competitors?
Some companies that are related to Allscripts Healthcare Solutions include Caci International (CACI), Science Applications International (SAIC), Parsons (PSN), Verint Systems (VRNT), Scientific Games (SGMS), NetScout Systems (NTCT), Sykes Enterprises (SYKE), Ebix (EBIX), Nextgen Healthcare (NXGN), Agilysys (AGYS), Ribbon Communications (RBBN), Simulations Plus (SLP), Onespan (OSPN), Tufin Software Technologies (TUFN) and Digimarc (DMRC).
What other stocks do shareholders of Allscripts Healthcare Solutions own?
Who are Allscripts Healthcare Solutions' key executives?
Allscripts Healthcare Solutions' management team includes the folowing people:
- Mr. Paul M. Black, CEO & Director (Age 61)
- Mr. Richard J. Poulton, Pres (Age 54)
- Mr. Dennis M. Olis, Chief Financial Officer (Age 56)
- Mr. Brian P. Farley, Exec. VP, Gen. Counsel, Corp. Sec. & Chief Admin. Officer (Age 49)
- Ms. Lisa Khorey, Exec. VP & Chief Client Delivery Officer (Age 52)
Who are Allscripts Healthcare Solutions' major shareholders?
Allscripts Healthcare Solutions' stock is owned by a number of of retail and institutional investors. Top institutional shareholders include Hennessy Advisors Inc. (0.58%), Pacer Advisors Inc. (0.04%) and State of Alaska Department of Revenue (0.02%). Company insiders that own Allscripts Healthcare Solutions stock include Brian Farley, Dennis Olis, James Hewitt, Mara G Aspinall, Michael Klayko, Paul Black, Richard J Poulton and Yancey L Spruill. View Institutional Ownership Trends for Allscripts Healthcare Solutions.
Which institutional investors are selling Allscripts Healthcare Solutions stock?
MDRX stock was sold by a variety of institutional investors in the last quarter, including Hennessy Advisors Inc. and Pacer Advisors Inc.. Company insiders that have sold Allscripts Healthcare Solutions company stock in the last year include Brian Farley and Richard J Poulton. View Insider Buying and Selling for Allscripts Healthcare Solutions.
Which institutional investors are buying Allscripts Healthcare Solutions stock?
MDRX stock was bought by a variety of institutional investors in the last quarter, including State of Alaska Department of Revenue. Company insiders that have bought Allscripts Healthcare Solutions stock in the last two years include Mara G Aspinall, Michael Klayko, Paul Black and Yancey L Spruill. View Insider Buying and Selling for Allscripts Healthcare Solutions.
How do I buy shares of Allscripts Healthcare Solutions?
Shares of MDRX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.
What is Allscripts Healthcare Solutions' stock price today?
One share of MDRX stock can currently be purchased for approximately $10.52.
How big of a company is Allscripts Healthcare Solutions?
Allscripts Healthcare Solutions has a market capitalization of $1.75 billion and generates $1.75 billion in revenue each year. The software maker earns $412.33 million in net income (profit) each year or $0.55 on an earnings per share basis. Allscripts Healthcare Solutions employs 9,500 workers across the globe.View Additional Information About Allscripts Healthcare Solutions.
What is Allscripts Healthcare Solutions' official website?
How can I contact Allscripts Healthcare Solutions?
Allscripts Healthcare Solutions' mailing address is 222 MERCHANDISE MART PLAZA SUITE 2024, CHICAGO IL, 60654. The software maker can be reached via phone at 800-334-8534 or via email at [email protected]
MarketBeat Community Rating for Allscripts Healthcare Solutions (NASDAQ MDRX)
MarketBeat's community ratings are surveys of what our community members think about Allscripts Healthcare Solutions and other stocks. Vote "Outperform" if you believe MDRX will outperform the S&P 500 over the long term. Vote "Underperform" if you believe MDRX will underperform the S&P 500 over the long term. You may vote once every thirty days.
